Position in GSK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$109,296,429
+$77,350,917 QoQ
Shares Held
2,085,014
+260.2% QoQ
Ownership
0.104%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#24
of 1,033 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 86%
Shared 0%
None 14%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $61,093,076,744 across 19 Drug Manufacturers - General names. GSK ranks #13 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
12,598,524 | $15,111,048,894 | |
| 2 | JNJ |
Johnson & Johnson
|
58,301,609 | $14,806,859,626 | |
| 3 | ABBV |
AbbVie Inc.
|
47,862,796 | $12,044,193,975 | |
| 4 | MRK |
Merck & Co., Inc.
|
43,886,420 | $5,639,404,964 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
71,713,442 | $4,132,128,518 | |
| 6 | AZN |
Astrazeneca PLC
|
19,204,823 | $3,641,618,528 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
20,820,621 | $2,630,477,247 | |
| 8 | AMGN |
Amgen Inc
|
3,588,484 | $1,299,461,817 |
All Filings in GSK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $109,296,429 | 2,085,014 | Shares | Other | 2026-08-12 | |
| 2026-03-31 | $31,945,512 | 578,828 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $111,900,302 | 2,281,817 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $101,426,126 | 2,350,003 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $85,991,151 | 2,239,353 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $15,501,459 | 400,141 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $45,793,088 | 1,354,024 | Shares | Other | 2025-02-12 | |
| 2024-09-30 | $15,158,910 | 370,815 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $48,936,038 | 1,271,066 | Shares | Other | 2024-12-26 | |
| 2024-03-31 | $74,666,159 | 1,741,688 | Shares | Other | 2024-12-26 | |
| 2023-12-31 | $39,186,462 | 1,057,379 | Shares | Other | 2024-12-26 | |
| 2023-09-30 | $24,749,428 | 682,743 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $31,739,838 | 890,568 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $11,441,064 | 321,559 | Shares | Sole | 2023-05-18 | |
| 2022-12-31 | $9,729,489 | 276,926 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $18,693,078 | 635,171 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $23,461,497 | 549,524 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $10,312,075 | 241,367 | Shares | Other | 2022-05-11 | |
| 2021-12-31 | $10,119,057 | 233,949 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $9,565,090 | 255,230 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $10,118,406 | 259,078 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $7,855,272 | 224,406 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $7,033,380 | 194,866 | Shares | Other | 2021-02-19 | |
| 2020-09-30 | $10,377,008 | 281,088 | Shares | Other | 2020-11-12 | |
| 2020-06-30 | $11,168,783 | 279,172 | Shares | Other | 2020-08-11 | |
| 2020-03-31 | $16,821,977 | 452,660 | Shares | Other | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||